Korea
J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025
Significant anti-tumor responses and reduction of brain metastases observed SEOUL, South Korea, June 1, 2025 /PRNewswire/ -- J INTS BIO, a company specializing in the development of therapeutics for cancer and rare diseases, officially announced interim results from the global Phase 1/2 clini...
GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal
YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in Genetics in Medicine, an SCIE-in...
CODIT Launches 'APEC 2025' Policy Monitoring Platform
* AI-Powered Legislative Insights: CODIT's Global Evidence-Based Policy Institute strengthens policy research and strategy SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- CODIT, an AI-powered leading GovTech firm, has launched a policy monitoring platform developed to support the upcoming 2025...
Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Neuronata-R®, an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral s...
Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities
Next-generation AI solution introduces new clinical features and broader disease detection for chest X-rays SEOUL, South Korea, May 28, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch and CE certifi...
Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik
The next-generation skin analysis platform, set to redefine the aesthetic
consultation experience
CAESAREA, Israel, May 27, 2025 /PRNewswire/ -- Alma
Pro Anime AI Video Generation Platform Animon.ai Launches in Korea
Key technology upgrades accompany market entry, providing an even better user experience TOKYO and SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- CreateAI Holdings ("CreateAI" or the "Company") today announced market entry in Korea and significant updates to its groundbreaking AI anime video g...
Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies
SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology (ASCO) ...
Nota AI Demonstrates On-Device AI Breakthrough at Embedded Vision Summit 2025 in Collaboration with Qualcomm AI Hub
* NetsPresso® and Qualcomm AI Hub: Strategic Integration Streamlines Edge AI Development * Generative AI solutions drive global expansion momentum ahead of IPO listing SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Nota AI, a global leader in AI optimization, showcased its latest edge AI inn...
VUNO Showcases DeepCARS® at AACN NTI 2025, Highlighting AI-Driven Cardiac Arrest Risk Prediction
– Company engages U.S. critical care professionals with data-driven early warning solution MARLBOROUGH, Mass., May 26, 2025 /PRNewswire/ -- VUNO, a global medical AI company, presented its flagship solution VUNO Med®–DeepCARS® at the 2025 National Teaching Institute & Critical Care Exposition (N...
Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths
* YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] * Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeabilit...
/DISREGARD RELEASE: Celltrion/
We are advised by Celltrion that journalists and other readers should disregard the news release, Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths, issued21-May-2025 over PR Newswire. ...
Dot Inc. Presented 'Inclusive AI' Innovations at Microsoft Build 2025
* Joining Microsoft's Copilot ecosystem, unveiling AI accessibility on the stage * 'Dot Vista' demo shows tactile conversion of visual content by leveraging Windows AI APIs and Copilot+ PCs * PowerPoint reimagined as a tactile interface for the visually impaired SEOUL, South Korea, May 22, ...
LG CNS showcases AI-Enhanced 'PerfecTwin ERP Edition' in the U.S. at SAP Sapphire 2025
* Introduces new PerfecTwin ERP Edition with AI capabilities such as real transaction data generation for testing and automated removal of sensitive information * Expands collaboration plans with SAP to provide technical enhanced services for cloud ERP advancement * Plans to establish ERP d...
SK hynix Develops UFS 4.1 Solution Based on 321-High NAND
* Optimized for on-device AI with best-in-class sequential reading performance, low power requirement * Thickness reduced by 15% to fit into ultra-slim flagship smartphones * Portfolio with world's highest 321-layer product to enhance SK hynix's leadership as full stack AI memory provider SE...
SK Networks President Sunghwan Choi encounters former UK Prime Minister
* Held a breakfast meeting with ex-UK Prime Minister Rishi Sunak during his visit toSouth Korea and discussed exchanges and AI cooperation between both nations. * Anticipations that strengthening collaboration with important global figures and entities will enhance the corporate value of SK N...
Neurophet Participates ASNR 2025: Showcasing Clinical Utility of 'Neurophet AQUA AD'
* Co-CEO Jake Junkil Been joins Industry Collaboration Session to present Neurophet's brain imaging analysis technologies, including Neurophet AQUA AD * Company accelerates partnerships with global pharmaceutical companies and neurology KOLs to drive collaboration in Alzheimer's disease clinic...
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
* No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 toRussia * Company plans to export PCV13 vaccine components * "We aim for the global PCV market with our 21-valent and next-generation pneumococcal vaccines currently...
STRADVISION Maintains ISO/IEC 27001 & 27701 Information Security Certifications for Five Consecutive Years
* In the era of autonomous driving, security is more than just technology; it
is the foundation of global trust. SEOUL, South Korea, May 20, 2025
/PRNewswire/ -- STRADVISION
LRQA reinforces Southeast Asia's role in Global Supply Chains at the 2025 Cascale Forum
HO CHI MINH CITY, Vietnam, May 20, 2025 /PRNewswire/ -- As the Asia Pacific region faces heightened scrutiny over supply chain sustainability, LRQA reaffirmed its dedication to responsible sourcing at the Cascale Forum: Ho Chi Minh City, held on May 14–15, 2025. This premier event convened manufa...
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025
[Picked up by 288 media titles]
2025-12-08 11:00Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 286 media titles]
2025-12-10 16:00